• PRINT SUBSCRIBERS |
  • SUBSCRIBE |
  • Login
  • My Account
  • (FREE ARTICLE)
weather icon

3

L/RAIN

TOKYO (6 a.m.)

  • Markets
  • 103.68 ¥/$ (5 p.m.)

The Japan Times

Avigan

  • Login
  • SUBSCRIBE
  • My Account
  • TODAY'S PRINT EDITION ≫
  • PRINT SUBSCRIBERS ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Reader Mail
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Avigan effectiveness not yet clear, Japan health ministry panel says

National / Science & Health Dec 22, 2020

Avigan effectiveness not yet clear, Japan health ministry panel says

The panel will continue its deliberations after determining that the results of clinical tests run by the drug's maker were not adequate to support its efficacy.

Japan's review of Avigan as COVID-19 treatment draws blank

National / Science & Health Dec 17, 2020

Japan's review of Avigan as COVID-19 treatment draws blank

The Pharmaceuticals and Medical Devices Agency raised questions about the way tests were performed and the criteria for determining whether symptoms had improved, sources say.

Fujifilm works with Shanghai firm to get Avigan approved in China

Business / Corporate Oct 22, 2020

Fujifilm works with Shanghai firm to get Avigan approved in China

Fujifilm Holdings Corp. said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co. to seek approval in China for Avigan to treat COVID-19 and influenza. Carelink will use Fujifilm's data on Avigan's treatment of novel coronavirus infections and influenza to seek imported drug approval ...

Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan

Business / Corporate Oct 16, 2020

Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan

The move comes after a late-stage study showed reduced recovery times for patients with nonsevere symptoms.

Japan denies plan to approve Avigan as COVID-19 treatment in November

National / Science & Health Oct 6, 2020

Japan denies plan to approve Avigan as COVID-19 treatment in November

In late September, the anti-flu drug's creator said that it would file for regulatory approval as early as October.

Japan planning quickest-ever approval for anti-viral drug Avigan

Science & Health Oct 4, 2020

Japan planning quickest-ever approval for anti-viral drug Avigan

According to sources, the government had already mapped out the drug's approval process by the time a Fujifilm unit disclosed data from clinical studies.

Avigan maker to seek virus treatment approval after trials show shortened recovery time

National / Science & Health Sep 23, 2020

Avigan maker to seek virus treatment approval after trials show shortened recovery time

Of 156 individuals described as "analysis targets," the median recovery time was 11.9 days in those receiving Avigan compared with 14.7 for patients given a placebo.

National / Science & Health Sep 21, 2020

Fujifilm completes delayed Avigan clinical test and looks to government application

Fujifilm Holdings Corp. said Monday it has completed delayed clinical tests of Avigan, a potential treatment for COVID-19, paving the way for the application of sales and production of the antivirus drug. Fujifilm Toyama Chemical Co., a subsidiary of Fujifilm Holdings, is conducting analysis of ...

Philippines begins nine-month clinical trial on Avigan in COVID-19 study

National / Science & Health Aug 17, 2020

Philippines begins nine-month clinical trial on Avigan in COVID-19 study

The Philippines started nine-month clinical trials for Avigan on Monday to study the efficacy of the Japanese anti-flu drug against the disease caused by the new coronavirus. Health Undersecretary Maria Rosario Vergeire said the clinical trials will include just four hospitals in Metro Manila initially ...

Fujifilm to complete delayed Avigan clinical trials in Japan in September

National Aug 13, 2020

Fujifilm to complete delayed Avigan clinical trials in Japan in September

Fujifilm Holdings Corp. said Thursday it expects to complete clinical tests in Japan of the antiviral drug Avigan, a potential candidate treatment drug for COVID-19, in September, already behind schedule after a delay caused by difficulty in securing enough patient data. The last patient will ...

Fujifilm to start another Avigan study in Kuwait following setback in Japan

National / Science & Health Jul 18, 2020

Fujifilm to start another Avigan study in Kuwait following setback in Japan

The trial is to be conducted with India's Dr. Reddy's Laboratories and will involve up to 1,000 people to assess the flu drug's effectiveness against the coronavirus.

Avigan's effectiveness inconclusive in Japan COVID-19 trial

National / Science & Health Jul 10, 2020

Avigan's effectiveness inconclusive in Japan COVID-19 trial

Promoted heavily by Prime Minister Shinzo Abe, the flu drug did not yield any statistically significant results after administered to 89 patients across Japan.

VIEW OLDER ARTICLES

  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • India must legalize same-sex marriage
    A participant holds a banner during an event promoting gay, lesbian, bisexual and transgender rights in Mumbai, India, in February 2020.
  • Japan to secure 310 million doses of COVID-19 vaccine, Suga says
    A French medical worker fills a syringe with the Pfizer-BioNTech vaccine against COVID-19 on Monday.
  • Tokyo court backs ban on Japanese holding dual nationality
    The Tokyo District Court has ruled in favor of Japan's ban on dual nationality.
  • Trump supporters rally in Tokyo against Biden's inauguration
    Supporters of U.S. President Donald Trump hold a rally in Tokyo on Wednesday ahead of the inauguration of President-elect Joe Biden in Washington.
  • Shocking concussion incident should be wake-up call for sumo
    In an infamous incident during the 2018 May Basho, Hokutofuji was defeated by Ryuden after appearing to sustain a concussion during a false start just moments earlier.
  • How will Biden deal with China?

    Thumbnail image
  • ‘Indian Migrants in Tokyo’ sheds light on an overlooked community

    Thumbnail image
  • Former SMAP stars test broadcast television’s relevance

    Thumbnail image
  • U.S. Senate confirms Lloyd Austin in historic vote, installing first Black defense secretary

    Thumbnail image
  • New virus variant may be somewhat deadlier, U.K. warns

    Thumbnail image
COVID-19 banner

PODCAST

  • DEEP DIVE

    Episode 78: Japan's foreign residents are trapped — Part 3

    LAST UPDATED: Jan 20, 2021

JAPAN NETWORK UPDATES

  • Directory of who’s who in the world of business in Japan

    LAST UPDATED: Jun 8, 2020

    JAPAN NETWORK UPDATES
Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha Jobs Study in Japan JT for Women JT Bookclub Japanese School Directory
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Reader Mail
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Privacy Policy
  • Link Policy
  • Reprints
  • FAQs
  • Support
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times